# Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

> **NCT06181994** · — · RECRUITING · sponsor: **Montefiore Medical Center** · enrollment: 5000 (estimated)

## Conditions studied

- Chronic Subdural Hematoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06181994
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-05
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-01-07

## Collaborators

- Geisinger Clinic
- Heidelberg University
- Henri Mondor University Hospital
- Ospedale Policlinico San Martino
- Ospedale San Raffaele
- Lehigh Valley Hospital
- Mayo Clinic
- Medical University of South Carolina
- New York University
- Oregon Health and Science University
- Sisters of Mercy University Hospital
- Unity Health Toronto
- Sutter Health
- University of Iowa
- Thomas Jefferson University
- University Health Network, Toronto
- University Hospital, Bordeaux
- University of Alabama at Birmingham
- University of South Florida
- University of Washington
- Cornell University
- Westchester Medical Center

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06181994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06181994, "Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT06181994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*